Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study.

Strongman, Helen; Korhonen, Pasi; Williams, Rachael; Bahmanyar, Shahram; Hoti, Fabian; Christopher, Solomon; Majak, Maila; Kool-Houweling, Leanne; Linder, Marie; Dolin, Paul; +1 more... Heintjes, Edith M; (2017) Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study. BMJ open diabetes research & care, 5 (1). e000364-. ISSN 2052-4897 DOI: https://doi.org/10.1136/bmjdrc-2016-000364

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1136/bmjdrc-2016-000364

Abstract

Share

Download

Filename: Pioglitazone and risk of_GOLD VoR.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar